Evidence map›Paper›PMID 42697735›Full record

ArticlePharmaceutical statistics

Accelerated Stability Studies: A Frequentist-Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package.

Bernard G Francq, Nikolaos Giannelos, Raymundo Sanchez, Marilena Paludi

Abstract read
In one paragraph

Article in Pharmaceutical statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bernard G FrancqGSK, Rixensart, Belgium.ORCID https://orcid.org/0000-0002-6183-387X
Nikolaos GiannelosGSK, Rixensart, Belgium.ORCID https://orcid.org/0000-0001-9130-4744
Raymundo SanchezGSK, Collegeville, Pennsylvania, USA.ORCID https://orcid.org/0009-0000-6869-8802
Marilena PaludiGSK, Siena, Italy.

Funding

GlaxoSmithKline Biologicals SA
6 · The paper itself

Abstract

Stability assessment of vaccine drug products typically requires years of data collection. Accelerated stability studies offer a practical alternative by leveraging high-temperature data collected over shorter time periods. We model degradation using arbitrary nth order kinetics and derive a closed-form solution that enables extrapolation across time and temperature. We compare interval estimation methods including the delta method, bootstrap resampling, and Bayesian inference and propose a frequentist-Bayesian hybrid (FBH) posterior approximation framework based on a multivariate Student's t-distribution. FBH is closely related to objective Bayesian inference under noninformative priors in simple Gaussian settings and fully propagates uncertainty in both model parameters and residual variance. Simulation results show that FBH outperforms standard approaches by consistently achieving nominal coverage, particularly in small-sample settings where competing methods exhibit undercoverage. The approach provides well-calibrated confidence and prediction intervals while maintaining computational efficiency comparable to analytical methods and avoiding the cost of full posterior sampling. The methodology is illustrated using two vaccine development case studies and implemented in the AccelStab R package.

Indexed as

Computer SimulationVaccinesBayes TheoremDrug StabilityModels, StatisticalVaccinesaccelerated stabilityArrheniuscoverage probabilitiesfrequentist–Bayesian hybridprediction intervalR packageSestak–Berggren

Identifiers

PMID42697735
PMCPMC13545001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.